La Jolla Institute for Allergy and Immunology
La Jolla, CA USA

Our News on Newswise

The Company You Keep

When fighting chronic viral infections or cancers, a key division of the immune system, known as CD8 T cells, sometimes loses its ability to effectively fight foreign invaders. Overcoming so-called T cell exhaustion is crucial to treating persistent...
12-Feb-2015 4:00 PM EST

La Jolla Institute Scientist Receives $1.6 Million Research Grant From American Diabetes Association

The American Diabetes Association (ADA) has awarded La Jolla Institute (LJI) researcher Stephanie Stanford, Ph.D., a $1.6 million grant to investigate the genetic and environmental factors that trigger the onset of type 1 diabetes.
9-Jan-2015 8:15 AM EST

La Jolla Institute Develops New Approach to Identify Genes Poised to Respond in Asthma Patients

In a study published yesterday in the scientific journal Nature Immunology, a group at the La Jolla Institute (LJI) led by Pandurangan Vijayanand, Ph.D. identify new genes that likely contribute to asthma, a disease that currently affects over 200...
8-Jul-2014 3:10 PM EDT

La Jolla Institute Advances Research Toward World’s First Vaccine for Heart Disease

Research toward the world’s first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
17-Jun-2014 6:00 AM EDT

La Jolla Institute Discovers New Mechanism for Unleashing Immune System Against Cancer

A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.
3-Apr-2014 3:00 PM EDT

La Jolla Institute Scientist Identifies Pivotal Cellular Protein Underlying Eczema

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema – a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.
9-Jan-2014 12:00 PM EST

Scientist Identifies Helper Cells That Trigger Potent Responses to HIV

A major new finding that will significantly advance efforts to create the world’s first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.
10-Sep-2013 6:25 PM EDT

La Jolla Institute Ranks Number One in World’s “Best Places to Work” in Science

La Jolla Institute for Allergy and Immunology has earned the Number 1 ranking in The Scientist magazine’s 2013 “Best Places to Work in Academia” survey of the worldwide academic research community.
8-Aug-2013 8:00 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos